Canaccord Genuity maintains a 'Buy' rating on Brightpoint (Nasdaq: CELL), raise PT to $10.

Canaccord analyst says, "We believe Brightpoint ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE